Client Testimonials

Therapeutic Proteins

Major Pharma Company
"John is the best in his field. His work is meticulous, timely, and high value"

Major Biotech Corporation
"John Adair is an outstanding scientist, he delivered the necessary scientific advice, asked the right questions, provided majority of prior art."

Apposite Capital
"John was our only choice to deliver the required sector expertise. He hits the sweet spot". Apposite "will definitely use Ithaka again for any project in this sector."

Biomarkers

Psynova Neurotech, Prof. Sabine Bahn, Director/ Co-Founder
"Paul has played a significant role in helping take Psynova Neurotech from a concept through to the launch of VeriPsychâ„¢, the first and only blood test to aid a psychiatrist in the diagnosis of recent-onset schizophrenia. As Chairman of the Board he has provided wise advice and support across all aspects of the business. He has been a delight to work with and his efforts are greatly appreciated by all the team at Psynova."

Commercialising Novel Technology - Universities

School of Marine Science & Technology, University of Newcastle Prof Grant Burgess,
"I have been very impressed by the market analysis undertaken by Ithaka around the potential value of our developing technology for the prevention and removal of bacterial biofilm. The information has been tremendously useful in providing the insight required to help take forward the research and in structuring deals and projects across a range of applications."

Strategic review

Local Enterprise Partnership in the North of England, 2011
"Thank you for all your hard work on this strategic review; we are very pleased with the breadth and depth of the research and the way in which Ithaka has engaged with so many different organisations across education, health and industry to produce our report."